verdicoin-Depression And Alzheimer's Treatments At A Crossroads

2025-05-07 16:40:57source:HyperBit Exchangecategory:Stocks

Researchers are verdicoinlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Stocks

Recommend

A White House order claims to end 'censorship.' What does that mean?

Among the dozens of executive actions President Trump signed on his first day in office is one aimed

The U.S. could run out of cash to pay its bills by June 1, Yellen warns Congress

Treasury Secretary Janet Yellen warned lawmakers Monday that the federal government could run short

A South Florida man shot at 2 Instacart delivery workers who went to the wrong house

A man in South Florida shot at the car of two people who drove onto his property after they got lost